sarpogrelate has been researched along with nitroarginine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hattori, K; Itoh, T; Kajikuri, J; Kodama, A; Komori, K; Yamanouchi, D | 1 |
| Itoh, T; Kajikuri, J; Kodama, A; Komori, K | 1 |
2 other study(ies) available for sarpogrelate and nitroarginine
| Article | Year |
|---|---|
Sarpogrelate hydrochloride reduced intimal hyperplasia in experimental rabbit vein graft.
Topics: Acetylcholine; Administration, Oral; Animals; Carotid Arteries; Cell Proliferation; Endothelium, Vascular; Enzyme Inhibitors; Hyperplasia; Jugular Veins; Male; Models, Animal; Nitric Oxide; Nitric Oxide Synthase Type III; Nitroarginine; Rabbits; Receptor, Serotonin, 5-HT2A; Serotonin 5-HT2 Receptor Antagonists; Serotonin Antagonists; Succinates; Superoxides; Tunica Intima; Vasodilation; Vasodilator Agents | 2009 |
Chronic treatment of hydroxytryptamine type 2a receptor antagonist sarpogrelate hydrochloride modulates the vasoreactivity of serotonin in experimental rabbit vein grafts.
Topics: Animals; Benzamides; Carotid Artery, Common; Dose-Response Relationship, Drug; Endothelium, Vascular; Enzyme Inhibitors; Graft Occlusion, Vascular; Jugular Veins; Male; Muscle, Smooth, Vascular; Nitric Oxide; Nitric Oxide Synthase; Nitroarginine; Pyridines; Rabbits; Receptor, Serotonin, 5-HT1B; Receptor, Serotonin, 5-HT2A; Serotonin; Serotonin 5-HT1 Receptor Antagonists; Serotonin 5-HT2 Receptor Antagonists; Serotonin Antagonists; Succinates; Vasoconstriction | 2009 |